| Time | Event | Speakers |
|---|---|---|
| 1:30 p.m. ET 12:30 p.m. CT 11:30 a.m. MT 10:30 a.m. PT | Welcome & Opening Presentation | Nichole Mercier, Washington University in St. Louis Kirsten Leute, Osage University Partners Amy Millman, Springboard Enterprises |
| Pitch Competition — 10 minute pitches, followed by 5-minute judge Q&A MedTech Breakout Room: 7 pitches Therapeutics Breakout Room: 7 pitches | ||
| 2 p.m. ET 1 p.m. CT Noon MT 11 a.m. PT | Pitch 1 MedTech Room — Jennifer Blain Christen, Arizona State University Startup: Flexbiotech, Inc. Technology: Low cost, point-of-care diagnostic systems for the screening of viral outbreaks and cancer in underserved populations Therapeutics Room — Juliane Bubeck Wardenburg, Washington University in St. Louis Technology: Adjuvanted single-component staphylococcus aureus vaccine for administration to infants and children in the primary vaccine series | |
| Pitch 2 MedTech Room — Maria Croyle, University of Texas at Austin Startup: Jurata Thin Film Technology: Thermo-resistant, rapidly dissolving MSI-TX film that stabilizes biologics at ambient temperatures Therapeutics Room — Ornit Chiba-Falek, Duke University Startup: Clairigene Technology: One-time, single treatment gene therapy to delay and/or slow the course of Alzheimer’s disease | ||
| Pitch 3 MedTech Room — Mary Driscoll, Yale University Startup: MIROTM Patient Centered Therapeutics Technology: Digital health application using image modification to process emotion and improve clinical and patient centered outcomes for individuals with pain Therapeutics Room — Sui Huang, Northwestern University Startup: CPU Therapeutics Technology: A novel, targeted therapy for liver and gastric cancers | ||
| 3 p.m. ET 2 p.m. CT 1 p.m. MT Noon PT | Pitch 4 MedTech Room — Nancy Guo, West Virginia University Startup: Sostos Technology: Novel gene assays for improving cancer diagnosis and prognosis Therapeutics Room — Julie Goodwin, Yale University Technology: Endothelial-cell specific WNT Inhibition; novel cell-targeted therapy for diabetic and non-diabetic renal fibrosis | |
| Pitch 5 MedTech Room — Ariella Shikanov, University of Michigan Startup: Artova Technology: Immuno-isolating capsules that restore physiological hormone function in girls who have undergone cancer treatment Therapeutics Room — Karin Westlund High, University of New Mexico Health Sciences Center Technology: Biologics focused on humanizing and optimizing small molecule, brain penetrant, single chain antibody therapies that reverse chronic neuropathic pain after a single dose | ||
| Pitch 6 MedTech Room — Katelyn Swindle-Reilly, The Ohio State University Startup: Vitranu, Inc. Technology: Tunable Extended Release CapsuleTM capable of delivering therapeutics to the back of the eye through intravitreal injection Therapeutics Room — Barbara Osborne, University of Massachusetts Amherst Startup: Hasentech Technology: Harnessing the anti-inflammatory effects of a bacterial exopolysaccharide (EPS) for the treatment of inflammatory diseases | ||
| 4 p.m. ET 3 p.m. CT 2 p.m. MT 1 p.m. PT | Pitch 7 MedTech Room — Danielle Tullman-Ercek, Northwestern University Startup: Opera Bioscience Technology: Bacterial platform that allows economic production of additional classes of proteins in bacterial systems, speeding time to market and reducing cost of goods Therapeutics Room — Monica Jablonski, University of Tennessee Health Science Center Startup: Oculotherapy Technology: Next generation therapy providing once-daily treatment for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension | |
| 4:45 p.m. ET 3:30 p.m. CT 2:45 p.m. MT 1:45 p.m. PT | Panel Discussion | |
| 5:15 p.m. ET 4:15 p.m. CT 3:15 p.m. MT 2:15 p.m. PT | Closing & Awards | Nichole Mercier, Washington University in St. Louis Kirsten Leute, Osage University Partners |
| 6:00 p.m. ET 5:00 p.m. CT 4:00 p.m. MT 3:00 p.m. PT | Event Concludes | |